Phlegmyheatclear

Author: ifci

August undefined, 2024

WebbSuccess rate during noninvasive ventilation in acute exacerbation of chronic obstructive pulmonary disease: a real-life study? Authors' reply主要由Antonello Nicolini、Lorenzo Ferrera Mario Santo、Maura Ferrari-Bravo Manuela Del Forno编写，在2015年被《Polish Archives of Internal Medicine》收录，原文总共1页。 Webb目的研究复方异丙托溴铵联合普米克令舒治疗老年急性加重慢性阻塞性肺病(aecopd)患者的临床疗效及对血清炎症因子的影响。方法选取医院收治的100例老年aecopd患者为研究对象,依据随机数字表法均分为对照组和观察组,每组50例,在常规治疗基础上,观察组患者联合应用复方异丙托溴铵与普米克令舒治疗 ...

International Medicine & Health Guidance News 2016 Issue 4 …

WebbAcute exacerbation of chronic obstructive pulmonary disease (AECOPD) is the leading cause of mortality in chronic obstructive pulmonary disease (COPD). Traditi Webb专利顾如平台提供关于 Shanghai kaibao pharmaceutical co ltd 的专利信息查询，本次查询共找到了7条关于 Shanghai kaibao pharmaceutical co ltd 的专利信息，专利顾如是创新者都在用的专利研发平台,专利检索,专利深度分析跟踪平台 css352

Success rate during noninvasive ventilation in acute exacerbation …

Webb痰热清治疗对aecopd患者症状、血气、肺功能指标及炎性因子水平的影响*俞洋欧阳洋杨晓龙张学人朱辉(上海中医药大学附属曙光医院急诊内科上海201203)摘要目的：探究痰热清对慢性阻塞性肺疾病发作加重期(aecopd)患者的症状、血气、肺功能指标及炎症反应的影响。 WebbWhat is claimed is: 1. An ophthalmic composition comprising: an oil mixture forming a stabilized oil emulsion in an aqueous phase, the oil mixture consisting essentially of … WebbAbstract: The invention discloses an application of phlegmyheatclear in preparation of a drug for treatment of acute exacerbation of chronic obstructive pulmonary disease. The … css 360度一直旋转

复方异丙托溴铵联合普米克令舒治疗急性加重慢性阻塞性肺病的效 …

Webbphlegmyheatclear dose rats drug chronic obstructive Prior art date 2024-07-07 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not … WebbAbstract: Disclosed is a method for producing algae-derived polyunsaturated fatty acids, comprising the steps of a) contacting dry algae with ethanol; b) removing ethanol to … ear bigWebbInternational Medicine & Health Guidance News Neoadjuvant chemotherapy in treatment of advanced gastric cancer and its influence on expression of related protein 2016 Issue 1007-1245 css370-40se-sc

"Webb目的：探讨自动变流在慢性阻塞性肺疾病(简称慢阻肺)急性加重合并Ⅱ型呼吸衰竭患者机械通气中的临床应用价值。rn 方法：对54例慢阻肺急性加重合并Ⅱ型呼吸衰竭患者进行经气管插管行机械通气治疗,给予同步间歇指令通气(SIMV)+压力支持通气(PSV),病情稳定后随机分为SIMV-PSV组(对照组)和SIMV-PSV+自动 ... " - Phlegmyheatclear

Phlegmyheatclear

Shanghai kaibao pharmaceutical co ltd的专利 - 专利顾如

WebbWhat is claimed is: 1. A composition comprising butyric acid or a salt thereof and Tamarindus indica extract. 2. The composition of claim 1, wherein the butyric acid salt is selected from the group consisting of calcium butyrate and sodium butyrate. WebbAbstract: The invention discloses an application of phlegmyheatclear in preparation of a drug for treatment of acute exacerbation of chronic obstructive pulmonary disease. The …

Did you know?

Webb目的:观察稳心颗粒对慢性阻塞性肺病急性加重(aecopd)合并窦性心动过速的心室率控制和对血液流变学的影响.方法:将80例符合诊断标准的患者随机分为治疗组44例,对照组36例；对照组给予抗感染、止咳化痰、解痉平喘、吸氧等治疗；治疗组在此基础上,加用稳心颗粒,每日3次,疗程2周.结果:两组在心室率 ... WebbUS20240008495A1 US17/160,090 US202417160090A US2024008495A1 US 20240008495 A1 US20240008495 A1 US 20240008495A1 US 202417160090 A US202417160090 A …

Webb31 dec. 2015 · Information on stock, financials, earnings, subsidiaries, investors, and executives for Shanghai Kaibao Pharmaceutical Company. Use the PitchBook Platform … Webb16 mars 2024 · 目的探讨小青龙汤加减治疗慢性阻塞性肺病急性加重(Acute Exacerbation of Chronic Obstructive Pulmonarydisease,AECOPD)的临床疗效。方法将2016年7月—2024年7月收治的64例AECOPD的患者作为研究对象,随机分为观察组和对照组,每组各32例,对照组给予西医常规治疗,观察组在对照组治疗的基础上采用小青龙汤剂加减治疗 ...

WebbMatch Document Document Title; 5251 : US20240009533 : METHOD FOR SENDING INFORMATION TO AN INDIVIDUAL LOCATED IN THE ENVIRONMENT OF A VEHICLE The present invention relates to a method for sending information to an individual (11) located in the environment of a vehicle (10), the method comprising the following steps: … WebbAU2024200606B2 - Application of phlegmyheatclear in preparation of drug for treatment of acute exacerbation of chronic obstructive pulmonary disease - Google Patents …

Webb12 juli 2024 · application of phlegmyheatclear in preparation of drug for treatment of acute exacerbation of chronic obstructive pulmonary disease （痰热清在制备慢性阻塞性肺病急性加重治疗药物中的应用） 2024200606 自2024年1月29 日起20年上海凯宝

Webb一站式科研服务平台. 学术工具. 文档翻译; 收录引证; 论文查重; 文档转换 css34.frWebbWhat is claimed is: 1. A composition comprising butyric acid or a salt thereof and Tamarindus indica extract. 2. The composition of claim 1, wherein the butyric acid salt is … ear bilaterallyWebbPhlegmyheatclear preparation is prepared from several components, that is, scutellaria baicalensis, bear gall powder, cornu gorais, honeysuckle flowers and fructus forsythia. … css361WebbApplication Of Phlegmyheatclear In Preparation Of Drug For Treatment Of ... 7/16/2024: Zhang, Xiaoli: Assignor: Application Publication: 16930652 20240015874: Use Of Bio … css 360兼容 css34p16 pdfWebbphlegmyheatclear group dose rats drug Prior art date 2024-07-07 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal … css 360旋转WebbThe invention discloses an application of phlegmyheatclear in preparation of a drug for treatment of acute exacerbation of chronic obstructive pulmonary disease. The present invention studies the effect of phlegmyheatclear on model of rats with acute … earbin outfiters